Royal Bank Of Canada Bio N Tech Se Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Bio N Tech Se stock. As of the latest transaction made, Royal Bank Of Canada holds 10,360 shares of BNTX stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,360

Previous 54,386 80.95%

Holding current value

$1.17 Million

Previous $4.37 Million 71.85%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$78.36 - $124.66 $3.45 Million - $5.49 Million	-44,026 Reduced 80.95%	10,360 $1.23 Million
Q2 2024 Aug 14, 2024	BUY	$80.36 - $102.87 $109,048 - $139,594	1,357 Added 2.56%	54,386 $4.37 Million
Q1 2024 Nov 05, 2024	SELL	$88.96 - $112.35 $120,718 - $152,458	-1,357 Reduced 2.5%	53,029 $4.89 Million
Q1 2024 May 15, 2024	BUY	$88.96 - $112.35 $1.66 Million - $2.1 Million	18,661 Added 54.3%	53,029 $4.89 Million
Q4 2023 Feb 14, 2024	BUY	$90.91 - $112.75 $2.57 Million - $3.19 Million	28,300 Added 466.38%	34,368 $3.63 Million
Q3 2023 Nov 14, 2023	SELL	$98.5 - $125.08 $271,761 - $345,095	-2,759 Reduced 31.26%	6,068 $659,000
Q2 2023 Aug 14, 2023	SELL	$102.58 - $129.66 $7,590 - $9,594	-74 Reduced 0.83%	8,827 $952,000
Q1 2023 May 15, 2023	SELL	$122.57 - $153.67 $80,896 - $101,422	-660 Reduced 6.9%	8,901 $1.11 Million
Q4 2022 Feb 14, 2023	SELL	$118.43 - $186.05 $266,704 - $418,984	-2,252 Reduced 19.06%	9,561 $1.44 Million
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $27,700 - $39,734	-217 Reduced 1.8%	11,813 $1.59 Million
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $1.4 Million - $2.12 Million	-11,366 Reduced 48.58%	12,030 $1.79 Million
Q1 2022 May 16, 2022	SELL	$126.25 - $231.85 $1.38 Million - $2.53 Million	-10,925 Reduced 31.83%	23,396 $3.99 Million
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $1.6 Million - $2.67 Million	7,364 Added 27.32%	34,321 $8.85 Million
Q3 2021 Nov 15, 2021	SELL	$205.93 - $447.23 $954,897 - $2.07 Million	-4,637 Reduced 14.68%	26,957 $7.36 Million
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $3.58 Million - $7.63 Million	31,594 New	31,594 $7.07 Million

Others Institutions Holding BNTX

# of Institutions

356

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Bio N Tech Se Transaction History